Literature DB >> 11182400

Severe glomerular sclerosis is not associated with poor outcome after kidney transplantation.

A D Lu1, D Desai, B D Myers, D C Dafoe, E J Alfrey.   

Abstract

BACKGROUND: The increased utilization of expanded criteria kidney donors has necessitated the reevaluation of multiple donor risk factors to insure the best outcome from this valuable resource. Reports of decreased graft survival in recipients of kidneys from donors with > or =20% glomerular sclerosis (GS) have led many transplant centers to refuse these donor kidneys. The purpose of this study is to compare outcome in recipients of cadaveric donor kidneys with > or =20% GS versus those with <20% or no GS at our center.
METHODS: We retrospectively reviewed 18 donor and 19 recipient and outcome variables in 89 recipients of kidneys, which were biopsied at the time of transplantation, between February 1995 and November 1998. We evaluated outcome based upon the percent of GS and the degree of vasculopathy.
RESULTS: Donors with > or =20% GS were older and had more hypertension. Recipients of kidneys with > or =20% GS were older, had higher serum creatinine values at 1 and 2 years, but similar rates of delayed graft function and 2-year graft survival. Vasculopathy did not correlate to any important donor criteria except the percent GS. However, serum creatinine was significantly higher in recipients of kidneys with moderate vasculopathy versus none, up to 2 years after transplantation. There was no significant difference in graft loss based upon vasculopathy.
CONCLUSION: Kidneys from donors with > or =20% GS provide excellent outcome similar to kidneys from donors with no GS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11182400     DOI: 10.1016/s0002-9610(00)00502-x

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

Review 1.  Assessment of kidney organ quality and prediction of outcome at time of transplantation.

Authors:  Thomas F Mueller; Kim Solez; Valeria Mas
Journal:  Semin Immunopathol       Date:  2011-01-28       Impact factor: 9.623

2.  Identification of biomarkers to assess organ quality and predict posttransplantation outcomes.

Authors:  Mariano J Scian; Daniel G Maluf; Kellie J Archer; Stephen D Turner; Jihee L Suh; Krystle G David; Anne L King; Marc P Posner; Kenneth L Brayman; Valeria R Mas
Journal:  Transplantation       Date:  2012-10-27       Impact factor: 4.939

3.  Optimal utilization of expanded criteria deceased donors for kidney transplantation.

Authors:  Theodore Karatzas; Athina Gompou; John Bokos; Dimitrios Dimitroulis; John Boletis; Alkiviadis Kostakis; Gregory Kouraklis; George Zavos
Journal:  Int Urol Nephrol       Date:  2011-03-04       Impact factor: 2.370

4.  Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant.

Authors:  Robert J Stratta; Michael S Rohr; Aimee K Sundberg; Greg Armstrong; Gloria Hairston; Erica Hartmann; Alan C Farney; Julie Roskopf; Samy S Iskandar; Patricia L Adams
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

5.  The role of procurement biopsies in acceptance decisions for kidneys retrieved for transplant.

Authors:  Bertram L Kasiske; Darren E Stewart; Bipin R Bista; Nicholas Salkowski; Jon J Snyder; Ajay K Israni; Gretchen S Crary; John D Rosendale; Arthur J Matas; Francis L Delmonico
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-20       Impact factor: 8.237

6.  Banff Histopathological Consensus Criteria for Preimplantation Kidney Biopsies.

Authors:  H Liapis; J P Gaut; C Klein; S Bagnasco; E Kraus; A B Farris; E Honsova; A Perkowska-Ptasinska; D David; J Goldberg; M Smith; M Mengel; M Haas; S Seshan; K L Pegas; T Horwedel; Y Paliwa; X Gao; D Landsittel; P Randhawa
Journal:  Am J Transplant       Date:  2016-07-22       Impact factor: 8.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.